Articles published by NovaBay Pharmaceuticals, Inc.
Via Business Wire
Tickers
NBY
Via Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
January 30, 2024
Via Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 09, 2023
Via Business Wire
Tickers
NBY
NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
November 02, 2023
Via Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
October 11, 2023
Via Business Wire
Tickers
NBY
Via Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
September 14, 2023
Via Business Wire
Tickers
NBY
Via Business Wire
Tickers
NBY
NovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023
August 08, 2023
Via Business Wire
Tickers
NBY
NovaBay Pharmaceuticals Reports Record Avenova Sales Day
July 14, 2023
Via Business Wire
Tickers
NBY
Via Business Wire
Tickers
NBY
Via Business Wire
Tickers
NBY
Via Business Wire
Tickers
NBY
Via Business Wire
Tickers
NBY
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.